Literature DB >> 7660450

The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni).

A J Trevett1, D G Lalloo, N C Nwokolo, S Naraqi, I H Kevau, R D Theakston, D A Warrell.   

Abstract

A prospective series of 156 patients systemically envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni) were studied. All patients were treated with appropriate antivenom and clinical course and outcome were compared. The proportion of patients requiring intubation was significantly smaller, and the time to resolution of neurotoxicity and discharge from hospital significantly shorter, in patients receiving antivenom no more than 4 h after the bite. No significant difference in outcome was demonstrated between patients receiving antivenom at various times after 4 h. No difference was demonstrated in the times to restoration of coagulability between the 2 groups. The only significant difference between a small number of patients given 2 vials of antivenom and patients given a single vial at the same time after envenoming was a marginally shorter duration of intubation in those who required it. The study suggests that, to achieve significant clinical benefit in Papuan taipan bite, antivenom must be given as early as possible.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660450     DOI: 10.1016/0035-9203(95)90562-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  13 in total

1.  Nerve terminal damage by beta-bungarotoxin: its clinical significance.

Authors:  R W Dixon; J B Harris
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

2.  Death adder envenoming causes neurotoxicity not reversed by antivenom--Australian Snakebite Project (ASP-16).

Authors:  Christopher I Johnston; Margaret A O'Leary; Simon G A Brown; Bart J Currie; Lambros Halkidis; Richard Whitaker; Benjamin Close; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

3.  Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

Authors:  Mariángela Vargas; Alvaro Segura; María Herrera; Mauren Villalta; Ricardo Estrada; Maykel Cerdas; Owen Paiva; Teatulohi Matainaho; Simon D Jensen; Kenneth D Winkel; Guillermo León; José María Gutiérrez; David J Williams
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

4.  Cerebellar infarct with neurogenic pulmonary edema following viper bite.

Authors:  Michael C Godpower
Journal:  J Neurosci Rural Pract       Date:  2012-01

Review 5.  Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry.

Authors:  John B Harris; Tracey Scott-Davey
Journal:  Toxins (Basel)       Date:  2013-12-17       Impact factor: 4.546

6.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

Review 7.  Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming.

Authors:  Anjana Silva; Wayne C Hodgson; Geoffrey K Isbister
Journal:  Toxins (Basel)       Date:  2017-04-19       Impact factor: 4.546

8.  Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa.

Authors:  Mamadou C Baldé; Jean-Philippe Chippaux; Mamadou Y Boiro; Roberto P Stock; Achille Massougbodji
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-03-28

Review 9.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10

10.  Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom.

Authors:  Matthew R Lewin; José María Gutiérrez; Stephen P Samuel; María Herrera; Wendy Bryan-Quirós; Bruno Lomonte; Philip E Bickler; Tommaso C Bulfone; David J Williams
Journal:  Toxins (Basel)       Date:  2018-09-20       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.